Quest Diagnostics (DGX) Receivables - Other (2009 - 2021)

Quest Diagnostics has disclosed Receivables - Other across 9 years of filings, most recently posting $5.0 million for Q1 2021.

• In Q1 2021, Receivables - Other changed 0.0% year-over-year to $5.0 million; the TTM figure through Mar 2021 stood at $5.0 million (changed 0.0% YoY), while the FY2020 annual figure was $3.0 million, down 25.0% from the prior year.
• Receivables - Other came in at $5.0 million for Q1 2021 at Quest Diagnostics, up from $3.0 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $13.0 million in Q2 2017 to a low of $3.0 million in Q4 2017.
• Average Receivables - Other over 5 years is $4.9 million, with a median of $4.0 million recorded in 2018.
• Year-over-year, Receivables - Other jumped 83.33% in 2017 and plunged 76.92% in 2018.
• Over 5 years, Receivables - Other stood at $3.0 million in 2017, then changed by 0.0% to $3.0 million in 2018, then surged by 33.33% to $4.0 million in 2019, then declined by 25.0% to $3.0 million in 2020, then jumped by 66.67% to $5.0 million in 2021.
• Per Business Quant data, the three most recent Receivables - Other figures were $5.0 million in Q1 2021, $3.0 million in Q4 2020, and $4.0 million in Q3 2020.